Industry
Stay updated with the latest trends, news, and developments in the UK medical cannabis industry, from regulations to market growth and innovations.
Reflecting on medical cannabis research: Yes We Can
Almost a year after launching, the Cannabis Industry Council’s ‘Yes We Can’ research report was published, revealing what UK based medical cannabis patients think about various aspects of the medical cannabis industry. Here, we take a look at what they found, and, what this could mean.
New 'Zero THC' regulation for UK CBD products
The Food Standards Agency (FSA)— the body responsible for the regulation of consumer CBD products in the UK—has hinted at ambitious new targets for CBD products in the UK market, which could see a push for zero detectable THC levels.
A UK first for medical cannabis patients: Releaf and Glass Pharms join forces to solve supply issues sustainably
Announced in The Sunday Times, Releaf have made history with the launch of a range of domestically, UK-grown medical cannabis cultivars. Releaf patient Chloe Durrington became the first person ever in the UK to receive prescribed medical cannabis flower that was grown here in the UK, by Glass Pharms®, just 200 miles from her home. Want to be among the first people in the UK to receive UK-grown medical cannabis on prescription? Check your eligibility here or speak to your Releaf clinician.
Releaf’s research recap: UK medical cannabis facts
At Releaf, one of our core commitments is to provide accurate, reliable and relevant information about medical cannabis treatments here in the UK, and in order to do this we’ve conducted our own research on numerous occasions.
Why medical cannabis is never prescribed in resin form
Cannabis-based medicinal products (CBMPs) are now prescribed in a variety of forms in the UK. But one product type you won’t find in the formulary is cannabis resin.
Real stories, Real impact: How we’re making a difference across the UK.
At Releaf, our mission is to enhance the quality of life of individuals across the UK by giving them back control of their health. And throughout 2024, as well as providing patient-focused care and unwavering support through our expert clinical and patient support teams, we’ve had the privilege of speaking with our patients one on one to find out more about their health journeys.
New Year, new me, new treatment: Medical cannabis in 2025.
Explore the potential of medical cannabis in 2025 as an alternative healthcare option in the UK. Learn how Releaf helps patients address health concerns like anxiety, chronic pain, and more with personalised, patient-centred treatment plans. Discover the benefits, conditions eligible for treatment, and how to take the first step toward a healthier you this New Year.
When to consider alternatives: 57% of generic medicines in the UK in short supply
While most people look for alternative treatment options because conventional medicines haven’t met their needs, an increase in prescription drug shortages in the UK is leaving more patients without access to effective medications.
Discussing medical cannabis at Christmas
With extended families coming together and immediate families typically spending long periods of time together over the Christmas period, catching up on what everyone has been up to over the last year is a common course conversation takes.
Medical cannabis accessories in the UK (2026): vapes, grinders, dosing caps
Medical cannabis flower can feel confusing at first, especially if you are new to vaporising. This 2026 guide breaks down the key medical cannabis accessories UK patients commonly use, including dry herb vaporisers, dosing capsules, and grinders for better preparation and more consistent dosing. You will also learn why these tools matter, what to avoid, and how the right setup can make your routine simpler and more reliable.
CBD, THC-Free and prescribed cannabis products: Clearing the confusion
Growing awareness and acceptance of cannabis-based products has been on the rise in recent years. In addition to a flourishing CBD consumer market, medical cannabis has become increasingly accessible to patients with a variety of health concerns.
Releaf Unwrapped: What we got up to in 2024
This year, we’ve taken a leaf from Spotify’s book and put together a collection of our favourite moments during 2024. As the year draws to a close, here we reflect on our milestones, growth, and most importantly, the transformative difference we’re making for patients.
Omura’s precision controlled dosing: What a difference a vape can make
We know what a difference the right vape can make, that’s why we’ve given out over £115,000 of Omura products to medical cannabis patients in the UK for free.
Planning a Winter retreat? What you need to know about travelling with medical cannabis
The holiday season is fast approaching, and with it, the yearly yearning to pack your bags, hit the road and hopefully escape the winter blues.
‘Tis the season: Refer a friend to Releaf
The days are drawing in and Christmas is right around the corner. Many of us will be working our way down Christmas lists, trying to find the perfect presents for our loved ones.
International Day of Persons with Disabilities: Celebrating Inclusivity with Releaf
Around the world, 1.3 billion, or 1 in 6, people live with a disability - yet many face barriers when accessing adequate healthcare services. At Releaf, it's important to us to participate in events like International Day of Persons with Disabilities, and so that’s exactly what we’re doing.
Can I get medical cannabis on the NHS?
There has been a huge resurgence in interest in plant-based health solutions in the past few decades. Not so long ago, most patients would just take whatever pharmaceutical options their GPs prescribed - but as we mature as a society and our collective understanding of alternative medicine grows, the understanding that plants can offer natural relief from a huge range of symptoms grows.
Disability History Month: How medical cannabis was legalised in the UK
Disability History Month, taking place from 14 November— 20 December highlights the history of the equality and human rights struggles of disabled individuals in the UK.
Medical cannabis and the NHS: A £4 billion solution for chronic pain
As new findings from an early health economic analysis suggest that prescribing medical cannabis on the NHS to treat chronic pain could save the state healthcare provider almost £4 billion every year, we take a closer look at the research.
How strong is medical cannabis flower?
When we discuss the 'strength' (or potency) of a given medical cannabis cultivar, it is easy to fall into the trap of simply looking at the THC levels. This is only one part of the picture - but a crucial one, nonetheless.
Six years of medical cannabis: What does it mean to you?
Friday the 1st of November 2024 marks six years of medical cannabis in the UK. For the last six years, (since November 1, 2018) specialist doctors like those working at Releaf have been able to prescribe medical cannabis flower, and cannabis oil, to eligible patients when traditional treatments have proved ineffective.
Drug Science Research: medical cannabis education amongst healthcare professionals
While awareness of medical cannabis has grown in recent years, there remains a huge knowledge gap when it comes to healthcare professionals and their understanding of this treatment.
Who uses medical cannabis in the UK?
Medical cannabis was legalised almost 6 years ago as an alternative treatment option for a large volume of health conditions when conventional approaches have proved ineffective.
Why medical cannabis is not prescribed for schizoaffective disorder in the UK
Medical cannabis has been prescribed for a wide range of conditions in the UK since the legislation of cannabis-based treatments on the 1st of November 2018. Since then, tens of thousands of patients have received a prescription for cannabis-based medicines; however, there are several conditions, including schizoaffective disorder, for which medical cannabis is not considered a suitable option. But why is this?